Correlation Between Medicus Pharma and Seres Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medicus Pharma and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicus Pharma and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicus Pharma Ltd and Seres Therapeutics, you can compare the effects of market volatilities on Medicus Pharma and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicus Pharma with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicus Pharma and Seres Therapeutics.

Diversification Opportunities for Medicus Pharma and Seres Therapeutics

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Medicus and Seres is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Medicus Pharma Ltd and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Medicus Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicus Pharma Ltd are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Medicus Pharma i.e., Medicus Pharma and Seres Therapeutics go up and down completely randomly.

Pair Corralation between Medicus Pharma and Seres Therapeutics

Given the investment horizon of 90 days Medicus Pharma Ltd is expected to generate 3.25 times more return on investment than Seres Therapeutics. However, Medicus Pharma is 3.25 times more volatile than Seres Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Seres Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  177.00  in Medicus Pharma Ltd on October 24, 2024 and sell it today you would earn a total of  97.00  from holding Medicus Pharma Ltd or generate 54.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy13.36%
ValuesDaily Returns

Medicus Pharma Ltd  vs.  Seres Therapeutics

 Performance 
       Timeline  
Medicus Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medicus Pharma Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Seres Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Seres Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Seres Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Medicus Pharma and Seres Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medicus Pharma and Seres Therapeutics

The main advantage of trading using opposite Medicus Pharma and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicus Pharma position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.
The idea behind Medicus Pharma Ltd and Seres Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world